Thursday, June 11, 2026

Intelligence Β· INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 132 of 200 Β· By data quality, then INN

  1. norelgestromin

    EVRA

    EMA: approved

    G03AA13
  2. nusinersen

    SPINRAZA Biogen

    EMA: approved Β· TGA: approved

    M09
  3. oblimersen

    GENASENSE

    EMA: refused

  4. octreotide

    OCTREOTIDE (SUN) Novartis Pharmaceuticals

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    H01CB02
  5. oestrogens conjugated

    DUAVIVE

    EMA: approved

    G03CC07
  6. olezarsen

    TRYNGOLZA

    EMA: approved

    C10AX
  7. olipudase alfa

    XENPOZYME

    EMA: approved Β· PMDA: approved

    A16AB25
  8. olopatadine

    OPATANOL

    EMA: approved

    S01GX09
  9. omalizumab

    OMLYCLO Novartis Pharmaceuticals

    FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    R03DX05
  10. omecamtiv mecarbil

    KINHARTO

    EMA: application withdrawn

    C01CX10
  11. onasemnogene abeparvovec

    ZOLGENSMA Novartis Pharmaceuticals

    EMA: approved Β· TGA: approved

    M09AX09
  12. oportuzumab monatox

    OPORTUZUMAB MONATOX DLRC PHARMA SERVICES

    EMA: application withdrawn

    L01FX06
  13. oritavancin

    TENKASI (PREVIOUSLY ORBACTIV)

    EMA: approved

    J01XA05
  14. oseltamivir

    EBILFUMIN

    EMA: approved Β· NMPA: clinical trials

    J05AH02
  15. osilodrostat

    ISTURISA Recordati Rare Diseases Australia Pty.

    EMA: approved Β· TGA: approved

    H02CA02
  16. osimertinib

    TAGRISSO AstraZeneca

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01XE
  17. ozanimod

    ZEPOSIA Bristol-Myers Squibb Australia Pty Ltd

    FDA: approved Β· EMA: approved Β· TGA: approved

    L04AA38
  18. padeliporfin

    TOOKAD

    EMA: approved

    L01XD07
  19. palivizumab

    SYNAGIS

    FDA: approved Β· EMA: approved

    J06BD01
  20. palonosetron

    PALONOSETRON DR.REDDY''S Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved

    A04AA05
  21. pancreas powder

    ENZEPI

    EMA: withdrawn

    A09AA02
  22. pandemic influenza vaccine (h1n1) (split virion, inactivated, adjuvanted)

    HUMENZA

    EMA: withdrawn

    J07BB02
  23. pandemic influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted)

    AREPANRIX

    EMA: withdrawn

    J07BB02
  24. pandemic influenza vaccine (h5n1) (live attenuated, nasal)

    PANDEMIC INFLUENZA VACCINE H5N1 ASTRAZENECA (PREVIOUSLY PANDEMIC INFLUENZA VACCINE H5N1 MEDIMMUNE)

    EMA: approved

    J07BB03

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.